Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07267806
Recruiting
Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC
Phase 3 · China · 1 site
Registry update: 16 Dec 2025
NCT07850128
Recruiting
Risk of Cervical Cancer Following Incident, Persistent and History-unknown HPV Detection
Not applicable · Sweden · 1 site
Registry update: 30 Sept 2026
NCT07129317
Recruiting
Pediatric Radiation Therapy Registry
Not applicable · United States · 2 sites
Registry update: 5 Nov 2025
NCT07792590
Recruiting
Registry for Prostate Cancer Focal Therapy
Not applicable · Hong Kong · 1 site
Registry update: 28 Aug 2026
NCT07205822
Recruiting
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Phase 3 · China, Spain, France, Italy, South Korea, United States · 35 sites
Registry update: 2 Oct 2026
NCT07332000
Recruiting
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Phase 2 · United States · 7 sites
Registry update: 15 Sept 2026
NCT06862739
Recruiting
Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination
Phase 4 · Pakistan · 2 sites
Registry update: 17 Apr 2026
NCT07123155
Recruiting
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
Phase 2 · Belgium, Germany, Denmark, Spain, France, United Kingdom, Italy, Netherlands, United States · 28 sites
Registry update: 23 Jun 2026
NCT06794229
Recruiting
Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
Phase 2 · United States · 4 sites
Registry update: 4 Sept 2026
NCT07796113
Recruiting
Adebrelimab With Famitinib and Chemotherapy as Neoadjuvant Therapy for ESCC
Phase 2 · China · 1 site
Registry update: 31 Aug 2026
NCT07858565
Recruiting
Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder
Not applicable · 1 site
Registry update: 15 Oct 2026
NCT06949280
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Not applicable · United States · 1 site
Registry update: 6 Nov 2026
NCT07182149
Recruiting
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Phase 1 · United States · 16 sites
Registry update: 18 Aug 2026
NCT07638345
Recruiting
DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions
Not applicable · Spain · 1 site
Registry update: 23 Jun 2026
NCT07082192
Recruiting
A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)
Phase 2/3 · China · 1 site
Registry update: 22 Sept 2026
NCT07420907
Recruiting
Study of the Progression of Chronic Cardiovascular Conditions
Not applicable · United States · 1 site
Registry update: 12 Aug 2026
NCT07173751
Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Phase 3 · Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, Germany, Spain, France, United Kingdom, Georgia, Italy, Japan, South Korea, Mexico, Netherlands, Poland, Singapore, United States · 245 sites
Registry update: 30 Oct 2026
NCT07263191
Recruiting
A Study of Olanzapine in Participants With Bipolar Disorder.
Not applicable · South Korea · 1 site
Registry update: 4 Dec 2025
NCT07026474
Recruiting
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC
Phase 3 · Switzerland, Germany · 24 sites
Registry update: 10 Sept 2026
NCT07302425
Recruiting
High-intensity Resistance Training in Post-exacerbation COPD
Not applicable · Italy · 1 site
Registry update: 24 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.